Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2025-12-25 @ 10:28 PM
NCT ID:
NCT02348658
Pre Assignment Details:
Healthy adult male participants were enrolled in 1 of 2 treatment sequences in either of the Periods 1 or 2: Sequence A: TAK-536TCH (combination drug of TAK-536 \[azilsartan\], amlodipine besilate \[AML\], hydrochlorothiazide \[HTZ\]) Fasted in Period 1+ TAK-536TCH Fed in period 2; Sequence B: TAK-536TCH Fed in Period 1+ TAK-536TCH Fasted in Period 2.
Recruitment Details:
Participants took part in the study at 1 investigative site in Japan from 29 January 2015 to 11 March 2015.
Study:
NCT02348658
Study Brief:
Results Section:
NCT02348658